Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

GlaxoSmithKline's India unit eyes sales growth after Novartis vax deal

29.05.2014 / Fierce Pharma

According to a local exec, good times are ahead for Glaxo's vaccines unit in India–and the company's recent pickup of Novartis' non-flu vaccine assets will help it get there.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: